Modeling neuroinflammation: hiPSC-derived microglia for compound screening

Presented by: Dr Jessica Tilman

Watch our webinar to learn how we’re using human iPSC-derived microglia to drive drug discovery. You can hear from Axol Senior Scientist (and microglia expert) Jess Tilman about how we’re using human iPSC-derived microglia to power neurodegenerative disease models and enable robust compound screening for early pre-clinical drug discovery.